Stay updated with breaking news from Adjunctive Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Orthofix Medical Inc. , a leading global spine and orthopedics company, today announced the presentation of multiple clinical and scientific abstracts during the International Society for the... | June 1, 2023
/PRNewswire/ -- CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and surveillance of Barrett's esophagus (BE) and dysplasia,...
Published: Apr 28, 2021 DURHAM, N.C.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc.. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced it will participate and have poster presentations at the virtual Association for Research and Vision in Ophthalmology (ARVO) Annual Meeting, to be held May 1-7, 2021. The posters will highlight topics ranging from additional research findings on...
Press release content from Business Wire. The AP news staff was not involved in its creation. Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting April 28, 2021 GMT DURHAM, N.C.--(BUSINESS WIRE)--Apr 28, 2021-- Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced it will participate ...